<?xml version="1.0" encoding="UTF-8"?>
<p>CaliciNet China uses database scripts provided by CaliciNet USA (
 <xref rid="R16" ref-type="bibr">
  <italic>16</italic>
 </xref>) and updated detection and dual genotyping protocols (
 <xref rid="R14" ref-type="bibr">
  <italic>14</italic>
 </xref>). The dual-typing method is helpful in clarifying the molecular epidemiology of noroviruses, including the identification of newly emerging recombinant viruses. For example, GII.4 Sydney[P31] predominated since it was first recognized in 2012 and subsequently became one of the most successful genotypes causing epidemics globally (
 <xref rid="R8" ref-type="bibr">
  <italic>8</italic>
 </xref>). In November 2015, this virus was gradually, although not completely, replaced by a new recombinant GII.4 virus, GII.P16-GII.4 Sydney (
 <xref rid="R7" ref-type="bibr">
  <italic>7</italic>
 </xref>), and has since caused â‰ˆ50% of all norovirus outbreaks in the United States (
 <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/norovirus/reporting/calicinet/data.html" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cdc.gov/norovirus/reporting/calicinet/data.html</ext-link>).
</p>
